$CRWV

Stocks Still Await Signs of Price Stability: Stock Market Today

U.S. indexes drifted lower as crude oil and interest rates were mostly flat, with investors awaiting the July CPI report. FactSet data for 88% of S&P 500 firms showed 86% positive earnings surprises and 76% positive revenue surprises. Nasdaq fell 0.6% to 26,445, S&P 500 0.3% to 7,728, Dow 0.3% to 53,791. CoreWeave (CRWV) and Super Micro (SMCI) report after the close; Nvidia (NVDA) and Intel (INTC) were also discussed.

Original reporting
Published Aug 12, 2026, 12:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 12:29 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stocks Still Await Signs of Price Stability: Stock Market Today — source image
Decision brief

The 30-second read

$CRWVNeutralMed
01

Why it matters

The main tradable catalysts are (1) CPI before the open Wednesday, which can reset rate expectations, and (2) after-close earnings for CoreWeave and Super Micro, where backlog and order intake expectations are central.

02

Market read

This is a market wrap plus an earnings calendar and a few company-specific catalysts, with CPI and rates as the dominant macro risk.

03

What to watch

The article highlights Middle East uncertainty and Strait of Hormuz control, which could reprice oil and rates quickly, changing the payoff of AI earnings trades.

Relevance 4/10Novelty 4/10Timing: ahead of Wednesday’s CPI release and after-close earnings for CRWV and SMCI

Background

Indexes drifted lower as crude oil and interest rates were mostly sideways, with investors waiting for July CPI and the September FOMC rate decision odds.

Company-level read

Ticker impact

$CRWVNeutralMedium confidence
Context

CoreWeave is scheduled to report after today’s close, with expectations for triple-digit revenue growth and a $99B backlog update.

Expected impact

High-volatility setup into the after-close print; direction depends on backlog and revenue growth vs expectations.

Evidence & confidence

The article provides specific consensus expectations and the timing (after today’s close), but no actual results yet.

$SMCINeutralMedium confidence
Context

Super Micro Computer is also on the earnings calendar after today’s close, with expectations for top-line growth above 100% and ~$60B in new orders.

Expected impact

Likely volatility around the print; upside skew if new orders and guidance confirm the ~$60B figure.

Evidence & confidence

The text is a forward-looking calendar item with concrete order-growth expectations, not a disclosed new datapoint.

$NVDANeutralLow confidence
Context

Nvidia is cited as the biggest mover of the AI boom, with markets reacting to a new $500B plan to support AI infrastructure spending.

Expected impact

Limited incremental edge; any move would likely track broader AI-infrastructure sentiment rather than a fresh NVDA catalyst.

Evidence & confidence

The $500B plan is mentioned as market approval, but the article does not provide new NVDA fundamentals or a new company action.

$INTCNeutralLow confidence
Context

Intel is described as reacting positively to an upsized $20B share offering as it seeks to expand capacity, alongside raised guidance from July 23 results.

Expected impact

Short-term trading likely dominated by dilution/financing interpretation; direction depends on how investors weigh capacity expansion vs dilution.

Evidence & confidence

The article references the offering and prior guidance, but does not provide new post-offering details or fresh filings in this text.

$CAHBullishMedium confidence
Context

Cardinal Health traded to a new intraday all-time high after mixed Q4 results but strong fiscal 2027 guidance, including EPS $12.40 to $12.60.

Expected impact

Near-term upside bias while traders digest fiscal 2027 EPS and segment growth assumptions; pullbacks possible if earnings quality or integration concerns emerge.

Evidence & confidence

This is the only ticker with a disclosed, time-relevant company-specific guidance range and a same-day price reaction described in the article.

$AHCONeutralLow confidence
Context

AdaptHealth is mentioned as +8.2% in connection with CAH’s announced deal to buy diabetes assets from AdaptHealth.

Expected impact

Potential sympathy move around deal headlines, but limited conviction without additional deal specifics.

Evidence & confidence

AHCO is referenced as a counterparty with a price move, not as the subject of a new disclosure in the text.

Market effects

AI infrastructure and hyperscaler budget growth remain the key sector narrative, with earnings and order/backlog expectations driving near-term positioning.

Primarily US-focused via S&P 500, Nasdaq, and Treasury yield moves; no explicit regional shock beyond rates and oil.

Oil and Middle East/Strait of Hormuz uncertainty are cited as macro risk factors that can spill into global risk appetite.

Counterpoint

Strong earnings breadth may already be priced, so CPI and rates could dominate and overwhelm single-stock earnings setups.

Key entities

  • CoreWeave

    AI native cloud platform scheduled to report after today’s close, with expectations for triple-digit revenue growth and a backlog update.

  • Super Micro Computer

    AI infrastructure supplier scheduled to report after today’s close, with expectations for top-line growth above 100% and ~$60B new orders.

  • Cardinal Health

    Medical services and products provider that hit a new intraday all-time high after issuing fiscal 2027 EPS guidance $12.40 to $12.60.

  • Intel

    Semiconductor company referenced for an upsized $20B share offering and prior guidance raise on July 23.

  • Nvidia

    AI leader referenced as benefiting from a new $500B plan to support AI infrastructure spending.

Related articles

$INTCMedAI 8/10

Intel raises $20 billion in upsized share sale to fund foundry push

Intel raised $20 billion via an upsized share offering priced at $95 per share on Aug. 11, a 2.6% discount to the prior close, after initially targeting $15 billion, according to the company and Bloomberg. Intel plans to fund foundry expansion and raised its 2024 capex forecast to $20 billion. Shares fell over 4% on Monday.

$NVDAMed

Nvidia scales back funding guarantee for Ohio OpenAI data center, WSJ reports

Reuters, citing the WSJ, says Nvidia scaled back its funding guarantee for a proposed OpenAI data center in Ohio. Nvidia is expected to initially guarantee less than $120 billion versus $250 billion previously discussed, covering only the first phase. A deal could be signed as soon as this weekend. OpenAI and Nvidia are nearing agreement; SB Energy (SoftBank unit) would develop the 10 GW site.

$NVDAMed

Goldman Sachs Mobilizes Investors for Nvidia’s AI Push

Goldman Sachs said it partnered with Nvidia to help set up independent compute platforms aimed at mobilizing more than $500 billion of third-party capital for AI infrastructure, subject to final agreements. Goldman will support debt placement via private credit and public markets, and provide junior capital and private credit financing through asset management. Other partners include Apollo, BlackRock, Blackstone, Brookfield and KKR.

$CBRSMedAI 8/10

Cerebras Sees Neo-Clouds Breaking Away From NVIDIA Dependence — Calls 2027 Opportunity ‘Large’

Cerebras Systems (CBRS) shares fell in premarket after mixed Q2 results. Adjusted loss was 4.5 cents per share versus a 17-cent estimate; revenue was $180.11M vs $194.20M consensus. Core revenue hit $209.9M, up 103% YoY, with core gross margin 40.6%. The company raised FY2026 outlook and expects 2027 growth tied to neo-cloud demand and reduced NVIDIA dependence.

$SMCIMedAI 8/10

AI infrastructure stocks surge after strong earnings from CoreWeave, Supermicro

AI infrastructure stocks rose Wednesday after strong earnings from Supermicro (SMCI) and AI cloud providers CoreWeave (CRWV) and Nebius (NBIS). Supermicro’s Q4 beat and forecast lifted shares over 6%. Nebius revenue topped expectations, while CoreWeave’s results showed accelerating demand and a surging backlog. Lumentum (LITE) revenue more than doubled to $1.01B, lifting peers and memory/storage ETFs.

$GSMed

Goldman’s latest cash cow is all about funding the AI infrastructure boom

CNBC reports Goldman Sachs is involved in AI-related financing announcements. Nvidia said Goldman and five other firms will help raise $500 billion for AI infrastructure financing, while Intel announced a $15 billion stock offering upsized to $20 billion with Goldman as joint book-running manager. Alphabet also sold $80 billion upsized to $85 billion, with Goldman involved. The article outlines how Goldman earns fees and trading revenue.